Cited by 5

The DOI matches its Crossref record.

Spatio-temporal regulation of EGFR signaling by the Eps15 homology domain-containing protein 3 (EHD3)

Amessou, Mohamed, Ebrahim, Abdul Shukkur, Dilly, Ashok, Joseph, Melvin, Tabolina, Marina, Chukkapalli, Sahiti, Meroueh, Louay, Syed, Joseph T., Liddane, Allison, Lang, Siera Lanae, Al-Katib, Ayad, Kandouz, Mustapha·2016·Oncotarget

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.13008

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Doxycycline-inducible EHD3 expression in EHD3-deleted glioblastoma cell lines increases basal levels of EGFR.

    “although doxycycline (Dox)-inducible EHD3 expression in EHD3-deleted glioblastoma cell lines increased the basal levels of EGFR (48).”
  • EHD3 may function in targeting ligand-stimulated EGFR to lysosomal degradation by diverting it from endocytic recycling.

    “A recent study suggested that EHD3 may function in targeting the ligand-stimulated EGFR to lysosomal degradation by diverting it from endocytic recycling (48), consistent with EHD3 deletion in glioblastoma (49), although doxycycline (Dox)-inducible EHD3 expression in EHD3-deleted glioblastoma cell lines increased the basal levels of EGFR (48).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 59

  1. Kleihues, 2007, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, 114, 97, 10.1007/s00401-007-0243-4 · DOI
  2. Kesari, 2008, Malignant gliomas in adults, N Engl J Med, 359, 492, 10.1056/NEJMra0708126 · DOI · Paper page
  3. Network TCGAR, 2008, Comprehensive genomic characterization defines human glioblastoma genes and core pathways, Nature, 455, 1061, 10.1038/nature07385 · DOI · Paper page
  4. Cavenee, 2007, Malignant astrocytic glioma: genetics, biology, and paths to treatment, Genes Dev, 21, 2683, 10.1101/gad.1596707 · DOI · Paper page
  5. Cai, 2010, Therapeutic targeting of EGFR in malignant gliomas, Expert Opin Ther Targets, 14, 303, 10.1517/14728221003598948 · DOI
  6. White, 2009, Oncogenic EGFR signaling networks in glioma, Sci Signal, 2, re6
  7. Salgia, 2006, Epidermal growth factor receptor-mediated signal transduction in the development and therapy of gliomas, Clin Cancer Res, 12, 7261, 10.1158/1078-0432.CCR-06-0874 · DOI
  8. Kandouz, 2014, Ehd3, a regulator of vesicular trafficking, is silenced in gliomas and functions as a tumor suppressor by controlling cell cycle arrest and apoptosis, Carcinogenesis, 35, 877, 10.1093/carcin/bgt399 · DOI
  9. Caplan, 2005, C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH?, J Cell Sci, 118, 4093, 10.1242/jcs.02595 · DOI · Paper page
  10. Caplan, 2008, Mechanisms of EHD/RME-1 protein function in endocytic transport, Traffic, 9, 2043, 10.1111/j.1600-0854.2008.00834.x · DOI · Paper page
  11. Caplan, 2006, Interactions between EHD proteins and Rab11-FIP2: a role for EHD3 in early endosomal transport, Mol Biol Cell, 17, 163, 10.1091/mbc.e05-05-0466 · DOI · Paper page
  12. Caplan, 2009, EHD3 regulates early-endosome-to-Golgi transport and preserves Golgi morphology, J Cell Sci, 122, 389, 10.1242/jcs.037051 · DOI
  13. Bunnett, 2009, Endosomes: a legitimate platform for the signaling train, Proc Natl Acad Sci USA, 106, 17615, 10.1073/pnas.0906541106 · DOI · Paper page
  14. Di Fiore, 2006, Endocytosis conducts the cell signaling orchestra, Cell, 124, 897, 10.1016/j.cell.2006.02.025 · DOI
  15. Miaczynska, 2009, Signaling from endosomes: location makes a difference, Exp Cell Res, 315, 1601, 10.1016/j.yexcr.2008.09.021 · DOI
  16. Di Fiore, 2010, The endocytic matrix, Nature, 463, 464, 10.1038/nature08910 · DOI
  17. von, 2009, Endocytosis and signalling: intertwining molecular networks, Nat Rev Mol Cell Biol, 10, 609, 10.1038/nrm2748 · DOI · Paper page
  18. Yarden, 2009, Systems biology of growth factor-induced receptor endocytosis, Traffic, 10, 349, 10.1111/j.1600-0854.2008.00870.x · DOI
  19. Di Fiore, 2008, Endocytosis and cancer: an ‘insider’ network with dangerous liaisons, Traffic, 9, 2011, 10.1111/j.1600-0854.2008.00816.x · DOI · Paper page
  20. Yarden, 2008, Derailed endocytosis: an emerging feature of cancer, Nat Rev Cancer, 8, 835, 10.1038/nrc2521 · DOI
  21. Di Fiore, 2004, Endocytosis and cancer, Curr Opin Cell Biol, 16, 156, 10.1016/j.ceb.2004.02.003 · DOI
  22. Goh, 2009, Endocytosis and intracellular trafficking of ErbBs, Exp Cell Res, 315, 683, 10.1016/j.yexcr.2008.07.029 · DOI
  23. Caplan, 2011, EHD proteins: key conductors of endocytic transport, Trends Cell Biol, 21, 122, 10.1016/j.tcb.2010.10.003 · DOI · Paper page
  24. Dikic, 2012, The role of ubiquitylation in receptor endocytosis and endosomal sorting, J Cell Sci, 125, 265, 10.1242/jcs.091280 · DOI
  25. Habib, 2015, Ligand-Independent EGFR Signaling, Cancer Res, 75, 3436, 10.1158/0008-5472.CAN-15-0989 · DOI
  26. Zerial, 2004, Not just a sink: endosomes in control of signal transduction, Curr Opin Cell Biol, 16, 400, 10.1016/j.ceb.2004.06.005 · DOI
  27. Wang, 2002, Internalization of inactive EGF receptor into endosomes and the subsequent activation of endosome-associated EGF receptors. Epidermal growth factor, Sci STKE, 2002, l17, 10.1126/stke.2002.161.pl17 · DOI
  28. Kuroki, 1986, Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture, Cancer Res, 46, 1648
  29. Mendelsohn, 1983, Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody, Proc Natl Acad Sci USA, 80, 1337, 10.1073/pnas.80.5.1337 · DOI
  30. Murayama, 1990, Growth-inhibitory effects of epidermal growth factor on human breast cancer and carcinoma of the esophagus transplanted into nude mice, Ann Surg, 211, 263
  31. Thomas, 1999, Effects of epidermal growth factor on MDA-MB-468 breast cancer cells: alterations in polyamine biosynthesis and the expression of p21/CIP1/WAF1, J Cell Physiol, 179, 257, 10.1002/(SICI)1097-4652(199906)179:3<257::AID-JCP3>3.0.CO;2-4 · DOI
  32. Yeudall, 1996, Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1) and alter cell cycle control in squamous carcinoma cells, Oncogene, 12, 2369
  33. Tartakoff, 1983, Perturbation of vesicular traffic with the carboxylic ionophore monensin, Cell, 32, 1026, 10.1016/0092-8674(83)90286-6 · DOI
  34. Rowe, 1990, Alteration of intracellular traffic by monensin; mechanism, specificity and relationship to toxicity, Biochim Biophys Acta, 1031, 225, 10.1016/0304-4157(90)90008-Z · DOI
  35. Murphy, 2013, SARA and RNF11 interact with each other and ESCRT-0 core proteins and regulate degradative EGFR trafficking, Oncogene, 32, 5220, 10.1038/onc.2012.554 · DOI
  36. Anderson, 2015, A kinase-independent role for EGF receptor in autophagy initiation, Cell, 160, 145, 10.1016/j.cell.2014.12.006 · DOI · Paper page
  37. Hung, 2008, Survival of cancer cells is maintained by EGFR independent of its kinase activity, Cancer Cell, 13, 385, 10.1016/j.ccr.2008.03.015 · DOI
  38. Wiley, 2001, Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking, Mol Biol Cell, 12, 1897, 10.1091/mbc.12.6.1897 · DOI
  39. Huitfeldt, 2001, Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF, Eur J Cell Biol, 80, 285, 10.1078/0171-9335-00160 · DOI
  40. Huber, 2007, Late endosomal traffic of the epidermal growth factor receptor ensures spatial and temporal fidelity of mitogen-activated protein kinase signaling, Mol Biol Cell, 18, 4698, 10.1091/mbc.e07-02-0098 · DOI
  41. Martin, 1991, Effect of epidermal growth factor on the proliferation of human epithelial cancer cell lines: correlation with the level of occupied EGF receptor, Anticancer Res, 11, 737
  42. Berthois, 1994, Relationship between the MAP kinase activity and the dual effect of EGF on A431 cell proliferation, Biochem Biophys Res Commun, 203, 984, 10.1006/bbrc.1994.2279 · DOI
  43. Berthois, 1996, Regulation of p42 mitogen-activated-protein kinase activity by protein phosphatase 2A under conditions of growth inhibition by epidermal growth factor in A431 cells, Eur J Biochem, 235, 97, 10.1111/j.1432-1033.1996.00097.x · DOI
  44. Berthois, 1998, Differential dose-dependent effects of epidermal growth factor on gene expression in A431 cells: evidence for a signal transduction pathway that can bypass Raf-1 activation, Endocrinology, 139, 2382, 10.1210/endo.139.5.5981 · DOI
  45. Muller, 1985, Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes, EMBO J, 4, 1193, 10.1002/j.1460-2075.1985.tb03759.x · DOI
  46. Reddy, 1996, Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity, Cell Growth Differ, 7, 173
  47. Ceresa, 2012, Endosomal accumulation of the activated epidermal growth factor receptor (EGFR) induces apoptosis, J Biol Chem, 287, 712, 10.1074/jbc.M111.294470 · DOI
  48. Wang, 2003, Stimulation of cell proliferation by endosomal epidermal growth factor receptor as revealed through two distinct phases of signaling, Mol Cell Biol, 23, 5803, 10.1128/MCB.23.16.5803-5815.2003 · DOI
  49. Wang, 2002, Endosomal signaling of epidermal growth factor receptor stimulates signal transduction pathways leading to cell survival, Mol Cell Biol, 22, 7279, 10.1128/MCB.22.20.7279-7290.2002 · DOI
  50. Stenmark, 2002, Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes, Nat Cell Biol, 4, 394, 10.1038/ncb791 · DOI · Paper page
  51. Emr, 2002, Receptor downregulation and multivesicular-body sorting, Nat Rev Mol Cell Biol, 3, 893, 10.1038/nrm973 · DOI · Paper page
  52. Park, 2003, Escape from Cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases, Cancer Cell, 3, 519, 10.1016/S1535-6108(03)00136-3 · DOI
  53. Stenmark, 2009, The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins, Nature, 458, 445, 10.1038/nature07961 · DOI · Paper page
  54. Borst, 2004, Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment, J Biol Chem, 279, 55465, 10.1074/jbc.M409765200 · DOI
  55. Madshus, 2004, Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation, Exp Cell Res, 300, 388, 10.1016/j.yexcr.2004.07.003 · DOI
  56. Yoshimori, 2008, Ubc4/5 and c-Cbl continue to ubiquitinate EGF receptor after internalization to facilitate polyubiquitination and degradation, Mol Biol Cell, 19, 3454, 10.1091/mbc.e07-10-0988 · DOI
  57. Bindokas, 2013, A function for EHD family proteins in unidirectional retrograde dendritic transport of BACE1 and Alzheimer's disease Abeta production, Cell Rep, 5, 1552, 10.1016/j.celrep.2013.12.006 · DOI · Paper page
  58. Reist, 1995, Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas, Cancer Res, 55, 3140
  59. Habib, 2006, Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells, Cancer Res, 66, 867, 10.1158/0008-5472.CAN-05-2753 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Amessou, M., Ebrahim, A. S., Dilly, A., Joseph, M., Tabolina, M., Chukkapalli, S., Meroueh, L., Syed, J. T., Liddane, A., Lang, S. L., Al-Katib, A., & Kandouz, M.
Affiliations
  • Department of Pathology, Wayne State University School of Medicine, Detroit, Michigan, USA
  • Lymphoma Research Lab, Wayne State University School of Medicine, Detroit, Michigan, USA
Venue
Oncotarget
Published
2016-11-01
Volume
7
Issue
48
Pages
79203-79216
ISSN
1949-2553
Cited by
5
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review